News | March 12, 2025
Aster DM Healthcare promoters reduce share pledge from 99% to 41%
The new lenders – JP Morgan, HSBC, and Barclays provided fresh funding
The new lenders – JP Morgan, HSBC, and Barclays provided fresh funding
This e-commerce platform is launched as a hyperlocal model
The study demonstrated equivalent efficacy, safety, immunogenicity, and pharmacokinetics between YESINTEK and the reference product Stelara
VITADEETM Green is a 100% plant-based Vitamin D3 suitable for food & nutraceuticals
The recent EU approval of MBL's plant has opened new avenues to explore such opportunities
Melicica has potential applications in skin repair, scar and acne-prone skin care, tone evening and brightening, texture improvement, baby care, sensitive skin solutions, post-procedure recovery and stretch mark care
Notably, 36 female students have been placed in Production and Manufacturing roles, reflecting the growing representation of women in core biotech operations
Company expects to begin building four more domestic manufacturing sites this year and add 13,000 high-wage manufacturing and construction jobs in America
Standalone profit from operations for Q4-2024 were Rs. 108 crore
YESINTEK is approved for the treatment of Crohn’s disease, ulcerative colitis, plaque psoriasis and psoriatic arthritis
Subscribe To Our Newsletter & Stay Updated
